Edition:
United States

Forward Pharma A/S (FWP.OQ)

FWP.OQ on NASDAQ Stock Exchange Global Select Market

3.66USD
12 Dec 2017
Change (% chg)

$-0.34 (-8.60%)
Prev Close
$4.01
Open
$4.00
Day's High
$4.00
Day's Low
$3.53
Volume
39,815
Avg. Vol
17,214
52-wk High
$32.70
52-wk Low
$3.53

Chart for

About

Forward Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in the development of FP187, a formulation of dimethyl fumarate (DMF) for the treatment of several inflammatory and neurological indications, including multiple sclerosis (MS). The Company's clinical candidate, FP187, is under development... (more)

Overall

Beta: --
Market Cap(Mil.): $188.74
Shares Outstanding(Mil.): 23.59
Dividend: 23.12
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 185.97 15.71
EPS (TTM): -- -- --
ROI: -- -11.84 31.93
ROE: -- -36.93 16.16

BRIEF-Forward Pharma Files Further Written Submissions In European Opposition Proceeding For EP2801355 Patent

* FORWARD PHARMA FILES FURTHER WRITTEN SUBMISSIONS IN THE EUROPEAN OPPOSITION PROCEEDING FOR THE EP2801355 PATENT IN PREPARATION FOR THE ORAL HEARING IN JANUARY 2018

Nov 29 2017

BRIEF-Forward Pharma announces completion of corporate restructuring plan

* Forward Pharma announces completion of corporate restructuring plan Source text for Eikon: Further company coverage:

Nov 22 2017

BRIEF-Forward Pharma board approves capital reduction

* Forward Pharma board of directors approves capital reduction and returns EUR 917.7 million to shareholders

Sep 01 2017

BRIEF-Forward Pharma obtains shareholder approval of capital reduction

* Forward Pharma obtains shareholder approval of the planned capital reduction at the extraordinary general meeting

Aug 02 2017

BRIEF-Forward Pharma announces planned distribution of EUR 19.45 per share to shareholders

* Forward Pharma announces planned distribution of EUR 19.45 per share to shareholders

Jul 18 2017

Earnings vs. Estimates